Literature DB >> 19659676

Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test.

Xuan Duc Nguyen1, Brigitte Flesch, Ulrich J Sachs, Hartmut Kroll, Harald Klüter, Michael Müller-Steinhardt.   

Abstract

BACKGROUND: White blood cell (WBC)-associated antibodies can lead to severe pulmonary transfusion reactions (transfusion-related acute lung injury [TRALI]). Investigation of a large number of blood donor samples using the standard granulocyte immunofluorescence test (GIFT) and granulocyte agglutination test (GAT) proved to be difficult to perform due to the time-consuming process and the large quantity of test cells required. This study describes the novel flow cytometric GIFT (Flow-GIFT) method for a rapid detection of granulocyte antibodies by flow cytometric analysis. STUDY DESIGN AND METHODS: A total of 141 sera were analyzed for the presence of granulocyte antibodies that were previously associated with suspected TRALI. As test cells whole blood samples from human neutrophil antigen (HNA)-typed donors were isolated using cell sedimentation in a ficoll density gradient. WBCs were incubated with the respective serum and binding of antibodies to the test cells was detected using fluorescein isothiocyanate-conjugated anti-human antibody. Standard GIFT and GAT were performed as reference methods.
RESULTS: Seven sera containing anti-HNA-3a, CD16, and HLA Class I were negative in the standard GIFT and eight sera containing anti-HNA-2a, anti-CD16, and anti-HLA Class I were not detected in the GAT. The novel Flow-GIFT was able to detect all granulocyte antibodies, which were only detectable in a combination of standard GIFT and GAT. In serial dilution tests, the Flow-GIFT detected the antibodies at higher dilutions than the reference methods GIFT and GAT.
CONCLUSION: The Flow-GIFT method permits rapid detection of granulocyte antibodies requiring fewer donor test cells. This method is ideal for automation and will potentially open the way for screening of granulocyte antibodies in a large donor population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659676     DOI: 10.1111/j.1537-2995.2009.02330.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  The frequency and specificity of human neutrophil antigen antibodies in a blood donor population.

Authors:  Jerome L Gottschall; Darrell J Triulzi; Brian Curtis; Ram M Kakaiya; Michael P Busch; Philip J Norris; Simone A Glynn; Danielle Carrick; David J Wright; Steve Kleinman
Journal:  Transfusion       Date:  2010-10-26       Impact factor: 3.157

2.  Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.

Authors:  Laura Porretti; Alessandra Cattaneo; Elena Coluccio; Elena Mantione; Federico Colombo; Mariagabriella Mariani; Georgia Bottelli; Silvia Mazzucchelli; Marco Pappalettera; Tiziana Speranza; Maurizio Migliari; Giuseppe Cambié; Daniele Prati; Paolo Rebulla
Journal:  Blood Transfus       Date:  2012-02-22       Impact factor: 3.443

3.  Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.

Authors:  Juliana Oliveira Martins; Elyse Moritz; Samira A Abbas; Larissa B Lopes; Melca M O Barros; Akemi K Chiba; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

4.  Multicenter Study on Differential Human Neutrophil Antigen 2 Expression and Underlying Molecular Mechanisms.

Authors:  Brigitte K Flesch; Angelika Reil; Núria Nogués; Carme Canals; Peter Bugert; Torsten J Schulze; Elly Huiskes; Leendert Porcelijn; Petter Höglund; Paul Ratcliffe; Marlies Schönbacher; Hans Kerchrom; Josina Kellershohn; Behnaz Bayat
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

5.  Leukocyte-Reactive Antibodies in Female Blood Donors: The Austrian Experience.

Authors:  Marlies Schönbacher; Nicole Aichinger; Lisa Weidner; Christof Jungbauer; Christoph Grabmer; Beate Schuha; Eva Rohde; Wolfgang Mayr; Günther Körmöczi
Journal:  Transfus Med Hemother       Date:  2020-09-23       Impact factor: 3.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.